Prof. Dr. Fulya Coşan
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Behcet Syndrome 8 publicationsSource: OpenAlex / PubMed MeSHView publications
- Lupus Erythematosus, Systemic 2 publications
- Spondylitis, Ankylosing 2 publications
Person ↔ Disease
Which topics does this doctor work on?
Medical areas of interest stated by the doctor on the institution profile. Source: medicalpark.com.tr.
- Romatoid artrit
- Spondiloartrit
- Psöriatik artrit
- Behçet hastalığı
- Ailevi akdeniz ateşi
- Gut hastalığı
- Vaskülit
CV
Education and experience
Education
- 2002İstanbul Üniversitesi İstanbul Tıp Fakültesi - Tıp Eğitimimedicalpark.com.tr
- 2007İstanbul Üniversitesi İstanbul Tıp Fakültesi - İç Hastalıkları - Uzmanlıkmedicalpark.com.tr
- 2007 - 2011İstanbul Üniversitesi İmmünoloji – Doktoramedicalpark.com.tr
- 2009 - 2012Kocaeli Üniversitesi Tıp Fakültesi - Romatoloji - Yan Dal Uzmanlıkmedicalpark.com.tr
- 2013 - 2015Bülent Ecevit Üniversitesi Tıp Fakültesi-Romatoloji-medicalpark.com.tr
- 2016 - 2018Bahcesehir Universitesi, Sosyal Bilimler Enstitusu, Felsefe AD- Yüksek Lisansmedicalpark.com.tr
- 2018Bahçeşehir Üniversitesi Tip Fakultesi-Profesörlükmedicalpark.com.tr
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyRheumatologymedicalpark.com.trFrom source
- InstitutionMedical Park Göztepemedicalpark.com.trFrom source
- Area of workBehcet SyndromeExtracted from 8 publications · Model version —From source
- Publications88 publicationsORCID, OpenAlexFrom source
- ORCID0000-0002-5630-8640ORCIDFrom source
- Last synchronised4 November 2026 20:27https://www.medicalpark.com.tr/hekimler/fulya-cosanmedicalpark.com.tr
Scientific work
Publications on Behcet Syndrome
-
Integrated stress response in Behcet disease: expression analyses in peripheral blood and synovial monocytes
Rheumatology International, 2025
DOI 10.1007/s00296-025-05972-7 PMID 40913636 Source: ORCID
-
ABS1252-PARE ARTIFICIAL INTELLIGENCE IN RHEUMATOLOGY HELATH CARE: A BIBLIOGRAPHIC ANALYSIS
Annals of the Rheumatic Diseases, 2025
DOI 10.1016/j.ard.2025.06.1328 Open-access full textSource: OpenAlex
-
EVALUATION OF CARDIAC INVOLVEMENT THROUGH TRANSTHORACIC DOPPLER ECHOCARDIOGRAPHY IN PATIENTS WITH RHEUMATOID ARTHRITIS
Rheumatology Quarterly, 2024
DOI 10.4274/qrheumatol.galenos.2023.57441 1 citation (OpenAlex) Open-access full textSource: ORCID
-
Clinical Characteristics and Management of Drug-Induced Lupus Caused by Tumor Necrosis Factor Inhibitors: A Comprehensive Review
Cureus, 2024
DOI 10.7759/cureus.72522 PMID 39606520 2 citations (OpenAlex) Open-access full textSource: OpenAlex
-
Clinical Characteristics and Management of Drug-Induced Lupus in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy
Cureus, 2024
DOI 10.7759/cureus.72388 PMID 39583374 1 citation (OpenAlex) Open-access full textSource: OpenAlex
-
THE RELATIONSHIP BETWEEN ANTI-CCP POSITIVITY AND CLINICAL/RADIOLOGICAL FINDINGS IN PATIENTS WITH PSORIATIC ARTHRITIS
2024
DOI 10.22541/au.170664825.55278154/v1 Open-access full textSource: OpenAlex
-
POS0669 FREQUENCY AND REASONS FOR NON-ACCEPTANCE OF TREATMENT CHANGE IN RHEUMATOID ARTHRITIS PATIENTS WHO WERE RECOMMENDED A TREATMENT CHANGE WITH A “TREAT TO TARGET” (T2T) TREATMENT STRATEGY
Annals of the Rheumatic Diseases, 2024
DOI 10.1136/annrheumdis-2024-eular.4075 Source: OpenAlex
-
POS0911 REASONS FOR NON-RESPONSE TO TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS CLASSIFIED AS DIFFICULT TO TREAT (D2T)
Annals of the Rheumatic Diseases, 2024
DOI 10.1136/annrheumdis-2024-eular.3950 Source: OpenAlex
-
AB1053 FOLLOW-UP DATA ON DRUG-INDUCED LUPUS CASES DURING TNF-ALPHA INHIBITOR TREATMENT
Annals of the Rheumatic Diseases, 2024
DOI 10.1136/annrheumdis-2024-eular.4018 Source: OpenAlex
-
Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy
BMC Rheumatology, 2023
DOI 10.1186/s41927-023-00342-x PMID 37468956 Open-access full textSource: ORCID